Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2018

Mar 1, 2018

30597_dirs_2018-02-28_52d88b1d-6efe-4006-8dbb-eddc3cd7a2eb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2018-02-27

Reporting Person: Elliott Jeffrey Thomas (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-27 Stock Option (right to buy) $44.37 A 16700 Acquired 2028-02-28 Common Stock (16700) Direct
2018-02-27 Restricted Stock Units $ A 20100 Acquired Common Stock (20100) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 21012 Direct
Common Stock 781 Indirect

Footnotes

F1: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.